Getting Tested: Timing is Important

The Eye Tumor Biopsy Must Be Taken Before Radiation

Once you have been diagnosed with primary uveal melanoma, if you choose to know your metastatic risk, a critical aspect is the timing involved in sampling your tumor. If you’re newly diagnosed, your doctor may already be discussing treatment of the eye tumor, in the majority of cases (80-90%) with some form of radiation therapy.

A sample of the eye tumor is collected with a fine needle aspirate biopsy

Once tumor tissue has been exposed to radiation, the test’s ability to provide meaningful results may be compromised. For this reason, the test cannot be run on radiated tissue. It is extremely important to have a discussion about the test with your treating doctor in the short window of time before radiation therapy (see “Talk to Your Doctor”).

Timing is not a critical issue if the treatment plan is enucleation, or removal of the eye.  In this case, tissue can be collected by needle biopsy right after the eye has been removed, or later, from the paraffin (a kind of wax) tissue block of the eye that is made following surgery, as is standard practice.

There is often a very short period of time between diagnosis and radiation treatment—and the tumor tissue sample required for DecisionDx®-UM test must be taken prior to radiation therapy.

Learn How DecisionDx®-UM
Can Help Determine
Your Personalized Risk


Timing Is Critical – Talk With Your Doctor

Our Discussion Guide Will Help Determine If DecisionDx-UM Is Right for You

Hear From Other Patients

Learn How DecisionDx-UM Has Made a Significant Impact on the Lives of Other Uveal Melanoma Patients.


What’s Next?

Overview of DecisionDx-UM

How Do You Get a
DecisionDx-UM Test?